1887
Rapid communications Open Access
Like 0

Abstract

Hepatitis C virus (HCV) infection is a serious public health problem in Europe, and it is estimated that a large number of people are unaware of their infection [1-3]. HCV infection may lead to symptomatic chronic liver disease after many years of asymptomatic infection. Effective treatment is available for HCV infection; however, the efficacy for many genotypes remains low and therapy is prolonged, involving both weekly injections and daily oral medication, and can be associated with significant adverse effects [4,5]. Where documented, injecting drug use is a major transmission route for HCV infections [1,6,7]. In many European countries, national surveillance of HCV infections has been established relatively recently.

Loading

Article metrics loading...

/content/10.2807/ese.13.21.18884-en
2008-05-22
2017-11-25
http://instance.metastore.ingenta.com/content/10.2807/ese.13.21.18884-en
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/13/21/art18884-en.htm?itemId=/content/10.2807/ese.13.21.18884-en&mimeType=html&fmt=ahah
Comment has been disabled for this content
Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error